Send feedback

SCN8A p.Ser845Pro

c.2533T>C · rs1057518356 · VCV373333

Likely pathogenic Expert panel
Classification
Likely pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.975 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
complex neurodevelopmental disorder

ClinGen expert panel — Epilepsy Sodium Channel VCEP

Likely Pathogenic for complex neurodevelopmental disorder. Applied ACMG criteria (verbatim):

PP3_Moderate PM2_Supporting PM5_Supporting PM1

Curation rationale (ClinGen, verbatim)

The NM_001330260.2:c.2533T>C variant in SCN8A is a missense variant predicted to cause substitution of serine by proline at amino acid 845 (p.Ser845Pro). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.960, which is above the threshold of 0.773, evidence that correlates with impact to SCN8A function (PP3_Moderate). Another missense variant (c.2534C>T (p.Ser845Phe), ClinVar Variation ID: 207109) in the same codon has been classified as likely pathogenic for autosomal dominant complex neurodevelopmental disorder by the ClinGen Epilepsy Sodium Channel VCEP (PM5_Supporting). This variant resides within a region, amino acids 844-852, of SCN8A that is defined as a mutational hotspot and/or critical functional domain by the ClinGen Epilepsy Sodium Channel VCEP (PM1). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant complex neurodevelopmental disorder based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP: PM1, PP3_Moderate, PM2_Supporting, PM5_Supporting. (VCEP specifications version 2.0.0; approved 8/26/25).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.975likely pathogenic ✓ concordant with ClinVar
REVEL0.96strongly pathogenic-leaning
SaProtLLR -10.41damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 1.7, phastCons 1
Regional constrainto/e 0.21constrained · MANE · 17 kb · p 8.5e-44 · regional, not allelic
Overall
CADD27.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene
SCN8A
Protein
p.Ser845Pro
Coding
c.2533T>C
MANE Select
NM_001330260
dbSNP
rs1057518356
Type
single nucleotide variant
Location
chr12:51762665 (GRCh38)
Gene constraint
LOEUF 0.189 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 68.90 · 7 PDB
Full SCN8A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

complex neurodevelopmental disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Non-specific syndromic intellectual disability (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Childhood, Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/scn8a-p-ser845pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown